Phase 3 Vaccination Clinical Trials
4 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–4 of 4 trials
Recruiting
Phase 3
Trial to Evaluate Immunogenicity Non-Inferiority, Safety and Lot-to-Lot Consistency of Biovac OCV-S to Euvichol®-Plus
Cholera Vaccination
International Vaccine Institute2,824 enrolled5 locationsNCT07304284
Recruiting
Phase 3
Pandemic Influenza Vaccine in Organ Transplantation (PIVOT Trial)
VaccinationInfluenza (Pandemic)Avian Influenza
University Health Network, Toronto120 enrolled1 locationNCT07240558
Recruiting
Phase 3
Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC
SafetyVaccinationChildren+3 more
Jean-Pierre Van geertruyden344 enrolled1 locationNCT06844487
Active
Phase 3
Preventing Invasive Pneumococcal Disease in Children & Adolescents with Leukaemia
Immunogenicity of pneumococcal vaccination in children and adolescents newly diagnosed with Leukaemia, with the aim to protect them from invasive pneumococcal disease
NHMRC CCRE in Childhood and Adolescent Immunisation100 enrolled1 locationACTRN12609000515291